Stroke prevention Deep vein thrombosis Pulmonary embolism
Manufactured under WHO-GMP compliant processes at our US FDA approved facility in Baddi, Himachal Pradesh.
Rigorous quality control at every stage ensures reliable purity and potency across every batch produced.
Trusted by pharmaceutical partners and distributors across 90+ countries worldwide.
Inhibits platelet activation and fibrin clot formation via direct, selective and reversible inhibition of free and clot-bound factor Xa (FXa). FXa, as part of the prothrombinase complex consisting also of factor Va, calcium ions, and phospholipid, catalyzes the conversion of prothrombin to thrombin.